Skip to main
DBD

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf has reported a strong growth trajectory, particularly in its Retail segment, with revenues reaching $255 million, reflecting an 8.1% quarterly increase and a 7.8% annual increase, alongside expanding gross margins. The company is expected to achieve free cash flow guidance of $190 million to $210 million by 2025, nearly doubling from $109 million in 2024, and it has delivered positive free cash flow for four consecutive quarters, underscoring its financial stability. Additionally, projected year-over-year EPS growth in 2026 is expected to be robust, supported by revenue growth and targeted improvements in gross and operating margins.

Bears say

Diebold Nixdorf Inc faces significant challenges that contribute to a negative outlook on its stock, primarily stemming from technological shortcomings and reduced demand for its products, which are exacerbated by increasing competition and pricing pressures. The company's Banking segment has reported a slight decline in gross margins to 26.8%, indicating potential difficulties in maintaining profitability amidst these market pressures. Additionally, ongoing risks such as tariff-related costs, supply chain disruptions, and liquidity issues further complicate the company's financial stability and forecasted performance.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Jan 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.